V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006234 | 200016647 | 1.72 | 61.6 | 02 | null | 2018-08-31 | Ipilimumab | null | N | IPILIMUMAB | 100829200 |
| 200006236 | 200016648 | 1.75 | 68 | Palliative (P) | 2019-02-21 | 2019-02-28 | DABRAFENIB | 02 | null | DABRAFENIB | 101170715 |
| 200006238 | 200016650 | 0 | 0 | Palliative (P) | 2020-02-19 | 2020-03-10 | Binimetinib + Encorafenib | 02 | null | DABRAFENIB | 100440453 |
| 200006239 | 200016651 | 1.91 | 79.1 | 03 | 2020-07-04 | 2020-08-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100695396 |
| 200006240 | 200016652 | 1.78 | 105.9 | Palliative (P) | 2020-02-18 | 2020-02-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100727387 |
| 200006243 | 200016653 | 1.62 | 68 | Palliative (P) | 2018-03-21 | 2018-04-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101545277 |
| 200006244 | 200016654 | null | 101 | Palliative (P) | 2021-11-13 | 2021-12-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100024829 |
| 200006254 | 200016659 | null | 88.7 | Palliative (P) | 2021-05-05 | 2021-05-07 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101098756 |
| 200006257 | 200016661 | null | 76.6 | null | null | 2018-10-14 | Irinotecan + Modified De Gramont | 02 | null | IPILIMUMAB | 101852285 |
| 200006260 | 200016662 | 1.77 | 50 | null | 2016-05-03 | 2016-05-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100189175 |
| 200006264 | 200016663 | 1.5 | 78.4 | 03 | 2018-11-16 | 2018-11-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101600683 |
| 200006265 | 200016664 | 1.65 | 103 | Palliative (P) | null | 2017-08-04 | null | null | N | VEMURAFENIB | 100924086 |
| 200006267 | 200016665 | 1.6 | 83.9 | Palliative (P) | null | 2019-10-09 | null | null | N | BINIMETINIB + ENCORAFENIB | 101002006 |
| 200006269 | 200016666 | 1.71 | 88 | Palliative (P) | 2019-08-28 | 2019-08-30 | DABRAFENIB | N | N | DABRAFENIB | 100503779 |
| 200006276 | 200016670 | null | 124 | Palliative (P) | 2020-11-12 | 2020-11-24 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB | 101770248 |
| 200006278 | 200016671 | 1.68 | 52.8 | Palliative (P) | 2018-09-07 | 2018-09-12 | Trial Unspecified | 02 | N | DABRAFENIB | 101564127 |
| 200006282 | 200016672 | 1.7 | 89.8 | Palliative (P) | 2016-05-06 | 2016-05-11 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100865135 |
| 200006283 | 200016673 | null | null | null | null | 2021-08-08 | null | null | null | CISPLATIN + GEMCITABINE | 101855769 |
| 200006290 | 200016677 | null | 74 | Curative (C) | 2020-11-02 | 2020-11-02 | Ipilimumab | 02 | N | IPILIMUMAB | 100977323 |
| 200006291 | 200016678 | null | null | null | null | 2019-03-03 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100857513 |
| 200006293 | 200016679 | 1.74 | 70.5 | 03 | null | 2021-08-28 | null | null | N | TEMOZOLOMIDE | 100366768 |
| 200006294 | 200016680 | 1.64 | 91.6 | 03 | 2021-08-31 | 2021-09-10 | Ipilimumab | 02 | N | IPILIMUMAB | 100777524 |
| 200006296 | 200016681 | 1.82 | 96.2 | Adjuvant (A) | 2020-05-27 | 2020-06-10 | null | null | null | IPILIMUMAB | 100441635 |
| 200006299 | 200016682 | 1.68 | 67.3 | Palliative (P) | 2019-08-26 | 2022-04-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB | 100596271 |
| 200006303 | 200016684 | null | null | null | null | 2017-01-11 | null | null | null | DABRAFENIB | 100906054 |
| 200006307 | 200016686 | 1.64 | 74.9 | Palliative (P) | null | 2018-03-07 | null | null | null | DABRAFENIB | 101639873 |
| 200006310 | 200016688 | null | 73.8 | Palliative (P) | 2017-09-04 | 2017-09-26 | Ipilimumab | null | null | IPILIMUMAB | 101165364 |
| 200006312 | 200016690 | 1.6 | null | null | null | 2021-04-12 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101190994 |
| 200006313 | 200016691 | null | null | null | null | 2018-05-14 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101036125 |
| 200006322 | 200016694 | 1.72 | 74 | null | null | 2020-10-15 | Ipilimumab | null | null | IPILIMUMAB | 100439382 |
| 200006325 | 200016695 | null | null | null | null | 2017-01-30 | null | null | null | DACARBAZINE | 100406898 |
| 200006326 | 200016696 | 1.6 | 94.2 | Palliative (P) | 2021-08-25 | 2021-12-31 | Ipilimumab | 02 | null | IPILIMUMAB | 101796085 |
| 200006331 | 200016698 | null | 108.6 | Palliative (P) | null | 2022-02-23 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100994031 |
| 200006333 | 200016699 | 1.57 | 75.6 | Palliative (P) | null | 2021-09-02 | null | null | null | TRIAL UNSPECIFIED | 101305056 |
| 200006334 | 200016700 | null | 79 | Palliative (P) | null | 2020-01-16 | null | null | N | BORTEZOMIB + MELPHALAN | 100710358 |
| 200006335 | 200016701 | null | 113 | Palliative (P) | null | 2020-02-06 | Ipilimumab | 02 | N | IPILIMUMAB | 101736131 |
| 200006338 | 200016703 | 1.65 | null | null | null | 2017-07-17 | null | null | null | TRIAL UNSPECIFIED | 100810821 |
| 200006340 | 200016704 | null | 75.6 | Curative (C) | null | 2018-12-30 | null | null | N | BORTEZOMIB + PANOBINOSTAT | 101092561 |
| 200006343 | 200016706 | 1.7 | null | Palliative (P) | 2019-06-19 | 2019-06-22 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100049485 |
| 200006344 | 200016707 | null | null | null | null | 2019-05-27 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101402562 |
| 200006345 | 200016708 | null | 93 | Adjuvant (A) | null | 2021-07-31 | null | null | N | TEMOZOLOMIDE | 101734354 |
| 200006347 | 200016710 | null | null | null | null | 2019-07-20 | null | null | null | DABRAFENIB | 101284535 |
| 200006349 | 200016711 | 1.68 | 98 | Palliative (P) | 2019-09-13 | 2019-09-17 | INTERIM Trial | 02 | null | IPILIMUMAB | 100173131 |
| 200006350 | 200016712 | 1.79 | 59.65 | Palliative (P) | null | 2019-10-07 | null | null | null | BINIMETINIB + ENCORAFENIB | 100643422 |
| 200006353 | 200016714 | 1.55 | 67.8 | Palliative (P) | null | 2019-01-19 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100418304 |
| 200006354 | 200016715 | 0 | 73.7 | Palliative (P) | 2020-10-20 | 2020-10-29 | Ipilimumab | 02 | null | IPILIMUMAB | 100576018 |
| 200006355 | 200016716 | null | null | null | null | 2021-04-13 | null | null | null | BINIMETINIB + ENCORAFENIB | 100696584 |
| 200006358 | 200016717 | null | null | null | 2019-12-13 | 2019-12-18 | null | 02 | null | BINIMETINIB + ENCORAFENIB | 101792855 |
| 200006360 | 200016718 | 1.81 | 64.3 | Palliative (P) | null | 2016-05-19 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101602508 |
| 200006364 | 200016720 | 1.94 | 72.2 | Palliative (P) | null | 2019-12-04 | null | null | N | IPILIMUMAB + NIVOLUMAB | 101645486 |